Skip to main content
NCBI home page
Heart logoLink to Heart
editorial
. 1997 May;77(5):393–394. doi: 10.1136/hrt.77.5.393

Atrial fibrillation begets trouble.

J E Waktare, A J Camm
PMCID: PMC484755  PMID: 9196403

Full text

PDF
393

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antman E. M., Beamer A. D., Cantillon C., McGowan N., Friedman P. L. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs. J Am Coll Cardiol. 1990 Mar 1;15(3):698–707. doi: 10.1016/0735-1097(90)90649-a. [DOI] [PubMed] [Google Scholar]
  2. Atwood J. E., Myers J. N., Sullivan M. J., Forbes S. M., Pewen W. F., Froelicher V. F. Diltiazem and exercise performance in patients with chronic atrial fibrillation. Chest. 1988 Jan;93(1):20–25. doi: 10.1378/chest.93.1.20. [DOI] [PubMed] [Google Scholar]
  3. Baker B. M., Botteron G. W., Smith J. M. Low-energy internal cardioversion for atrial fibrillation resistant to external cardioversion. J Cardiovasc Electrophysiol. 1995 Jan;6(1):44–47. doi: 10.1111/j.1540-8167.1995.tb00756.x. [DOI] [PubMed] [Google Scholar]
  4. Cannegieter S. C., Rosendaal F. R., Wintzen A. R., van der Meer F. J., Vandenbroucke J. P., Briët E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med. 1995 Jul 6;333(1):11–17. doi: 10.1056/NEJM199507063330103. [DOI] [PubMed] [Google Scholar]
  5. Coplen S. E., Antman E. M., Berlin J. A., Hewitt P., Chalmers T. C. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation. 1990 Oct;82(4):1106–1116. doi: 10.1161/01.cir.82.4.1106. [DOI] [PubMed] [Google Scholar]
  6. Crijns H. J., Van Gelder I. C., Van Gilst W. H., Hillege H., Gosselink A. M., Lie K. I. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. Am J Cardiol. 1991 Aug 1;68(4):335–341. doi: 10.1016/0002-9149(91)90828-9. [DOI] [PubMed] [Google Scholar]
  7. Dahlström C. G., Edvardsson N., Nasheng C., Olsson S. B. Effects of diltiazem, propranolol, and their combination in the control of atrial fibrillation. Clin Cardiol. 1992 Apr;15(4):280–284. doi: 10.1002/clc.4960150411. [DOI] [PubMed] [Google Scholar]
  8. Ezekowitz M. D., James K. E., Nazarian S. M., Davenport J., Broderick J. P., Gupta S. R., Thadani V., Meyer M. L., Bridgers S. L. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Circulation. 1995 Oct 15;92(8):2178–2182. doi: 10.1161/01.cir.92.8.2178. [DOI] [PubMed] [Google Scholar]
  9. Feinberg W. M., Seeger J. F., Carmody R. F., Anderson D. C., Hart R. G., Pearce L. A. Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation. Arch Intern Med. 1990 Nov;150(11):2340–2344. [PubMed] [Google Scholar]
  10. Flaker G. C., Blackshear J. L., McBride R., Kronmal R. A., Halperin J. L., Hart R. G. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol. 1992 Sep;20(3):527–532. doi: 10.1016/0735-1097(92)90003-6. [DOI] [PubMed] [Google Scholar]
  11. Friedman H. S., Scorza J., McGuinn R., Shaughnessy E. The effects of atrial fibrillation on myocardial blood flow and energetics. Proc Soc Exp Biol Med. 1985 Oct;180(1):1–8. doi: 10.3181/00379727-180-42135. [DOI] [PubMed] [Google Scholar]
  12. Geschwind H., Huet Y., Laine J. F., Teisseire B., Dhainaut J. F., Laurent D. Coût énergétique de la potentialisation post-extrasystolique chez l'homme. Arch Mal Coeur Vaiss. 1984 Jul;77(7):747–753. [PubMed] [Google Scholar]
  13. Gold R. L., Haffajee C. I., Charos G., Sloan K., Baker S., Alpert J. S. Amiodarone for refractory atrial fibrillation. Am J Cardiol. 1986 Jan 1;57(1):124–127. doi: 10.1016/0002-9149(86)90964-1. [DOI] [PubMed] [Google Scholar]
  14. Grogan M., Smith H. C., Gersh B. J., Wood D. L. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol. 1992 Jun 15;69(19):1570–1573. doi: 10.1016/0002-9149(92)90705-4. [DOI] [PubMed] [Google Scholar]
  15. Haiat R., Halphen C., Stoltz J. P., Leroy G., Soussana C. La fibrillation auriculaire: une cause de cardiomyopathie réversible. Ann Cardiol Angeiol (Paris) 1987 Oct;36(8):417–419. [PubMed] [Google Scholar]
  16. Hylek E. M., Skates S. J., Sheehan M. A., Singer D. E. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med. 1996 Aug 22;335(8):540–546. doi: 10.1056/NEJM199608223350802. [DOI] [PubMed] [Google Scholar]
  17. Lang R., Klein H. O., Weiss E., David D., Sareli P., Levy A., Guerrero J., Di Segni E., Kaplinsky E. Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation. Chest. 1983 Mar;83(3):491–499. doi: 10.1378/chest.83.3.491. [DOI] [PubMed] [Google Scholar]
  18. Lewis R. V., Irvine N., McDevitt D. G. Relationships between heart rate, exercise tolerance and cardiac output in atrial fibrillation: the effects of treatment with digoxin, verapamil and diltiazem. Eur Heart J. 1988 Jul;9(7):777–781. doi: 10.1093/eurheartj/9.7.777. [DOI] [PubMed] [Google Scholar]
  19. Lipkin D. P., Frenneaux M., Stewart R., Joshi J., Lowe T., McKenna W. J. Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinus rhythm. Br Heart J. 1988 May;59(5):572–577. doi: 10.1136/hrt.59.5.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lévy S., Lauribe P., Dolla E., Kou W., Kadish A., Calkins H., Pagannelli F., Moyal C., Bremondy M., Schork A. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation. 1992 Nov;86(5):1415–1420. doi: 10.1161/01.cir.86.5.1415. [DOI] [PubMed] [Google Scholar]
  21. Naito M., David D., Michelson E. L., Schaffenburg M., Dreifus L. S. The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. Am Heart J. 1983 Aug;106(2):284–291. doi: 10.1016/0002-8703(83)90194-1. [DOI] [PubMed] [Google Scholar]
  22. Peters K. G., Kienzle M. G. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm. Am J Med. 1988 Aug;85(2):242–244. doi: 10.1016/s0002-9343(88)80352-8. [DOI] [PubMed] [Google Scholar]
  23. Petersen P., Madsen E. B., Brun B., Pedersen F., Gyldensted C., Boysen G. Silent cerebral infarction in chronic atrial fibrillation. Stroke. 1987 Nov-Dec;18(6):1098–1100. doi: 10.1161/01.str.18.6.1098. [DOI] [PubMed] [Google Scholar]
  24. Pomfret S. M., Beasley C. R., Challenor V., Holgate S. T. Relative efficacy of oral verapamil and digoxin alone and in combination for the treatment of patients with chronic atrial fibrillation. Clin Sci (Lond) 1988 Apr;74(4):351–357. doi: 10.1042/cs0740351. [DOI] [PubMed] [Google Scholar]
  25. Rodriguez L. M., Smeets J. L., Xie B., de Chillou C., Cheriex E., Pieters F., Metzger J., den Dulk K., Wellens H. J. Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol. 1993 Nov 15;72(15):1137–1141. doi: 10.1016/0002-9149(93)90982-i. [DOI] [PubMed] [Google Scholar]
  26. Shapiro E. P., Effron M. B., Lima S., Ouyang P., Siu C. O., Bush D. Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm. Am J Cardiol. 1988 Dec 1;62(17):1202–1207. doi: 10.1016/0002-9149(88)90260-3. [DOI] [PubMed] [Google Scholar]
  27. Sopher S. M., Murgatroyd F. D., Slade A. K., Blankoff I., Rowland E., Ward D. E., Camm A. J. Low energy internal cardioversion of atrial fibrillation resistant to transthoracic shocks. Heart. 1996 Jun;75(6):635–638. doi: 10.1136/hrt.75.6.635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Ueshima K., Myers J., Morris C. K., Atwood J. E., Kawaguchi T., Froelicher V. F. The effect of cardioversion on exercise capacity in patients with atrial fibrillation. Am Heart J. 1993 Oct;126(4):1021–1024. doi: 10.1016/0002-8703(93)90732-o. [DOI] [PubMed] [Google Scholar]
  29. Van Gelder I. C., Crijns H. J., Blanksma P. K., Landsman M. L., Posma J. L., Van Den Berg M. P., Meijler F. L., Lie K. I. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol. 1993 Sep 1;72(7):560–566. doi: 10.1016/0002-9149(93)90352-d. [DOI] [PubMed] [Google Scholar]
  30. Van Gelder I. C., Crijns H. J., Van Gilst W. H., Van Wijk L. M., Hamer H. P., Lie K. I. Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter. Am J Cardiol. 1989 Dec 1;64(19):1317–1321. doi: 10.1016/0002-9149(89)90574-2. [DOI] [PubMed] [Google Scholar]
  31. Wijffels M. C., Kirchhof C. J., Dorland R., Allessie M. A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995 Oct 1;92(7):1954–1968. doi: 10.1161/01.cir.92.7.1954. [DOI] [PubMed] [Google Scholar]
  32. Wolf P. A., Abbott R. D., Kannel W. B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991 Aug;22(8):983–988. doi: 10.1161/01.str.22.8.983. [DOI] [PubMed] [Google Scholar]
  33. Wolf P. A., Dawber T. R., Thomas H. E., Jr, Kannel W. B. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978 Oct;28(10):973–977. doi: 10.1212/wnl.28.10.973. [DOI] [PubMed] [Google Scholar]
  34. van den Berg M. P., van Veldhuisen D. J., Crijns H. J., Lie K. I. Reversion of tachycardiomyopathy after beta-blocker. Lancet. 1993 Jun 26;341(8861):1667–1667. doi: 10.1016/0140-6736(93)90808-t. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES